Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Placebo Control

Aliases
Normal Saline, Placebo

5 clinical trials

4 indications

Indication
Osteoarthritis
Indication
Epilepsy
Indication
Dravet syndrome
Indication
Focal Seizures
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade (KLG) 2 or 3 Osteoarthritis of the Knee
Status: Recruiting, Estimated PCD: 2024-08-30
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 Osteoarthritis of the Knee
Status: Active (not recruiting), Estimated PCD: 2024-03-06
Clinical trial
A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome.
Status: Completed, Estimated PCD: 2018-04-09
Clinical trial
A Double Blind, Randomized, Placebo-controlled, Two-part Study to Investigate the Pharmacokinetics, Followed by Efficacy and Safety of GWP42006 as add-on Therapy in Patients With Inadequately Controlled Focal Seizures.
Status: Completed, Estimated PCD: 2017-07-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Determine the Efficacy, Safety, and Dosing of TG-C in Adult Subjects With Symptomatic Early Hip Osteoarthritis
Status: Not yet recruiting, Estimated PCD: 2025-10-01